AzTrials
AzTrials

Recurrent Urinary Tract InfectionSARUTINCT02705495

Acupuncture for Prevention of Recurrent Urinary Tract Infections.

A study testing acupuncture and Cranberry products in people with Recurrent Urinary Tract Infection, run by Medical University of Graz at 1 site in Austria.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In this multi-centre prospective randomized controlled trial the efficacy of segmental acupuncture in the prevention of recurrent urinary tract infections will be assessed. The study (acupuncture) group will receive 12 acupuncture treatments according to a standardized protocol, plus recommendation for use of… Read more about this study

Who is it for?
Ages 18 to 90 years, women only
Conditions the study is for
Recurrent Urinary Tract Infection
What is being tested?
acupuncture and Cranberry products
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
136 participants
Where
1 siteAustria
Study dates
May 2015to Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Recurrent UTIs: Two or more symptomatic UTIs within the last six 6 months or 3 or more infections within the last 12 months.
  • At least two positive urine culture within this period of time
  • No evidence of current UTI at the time of inclusion
  • Women, Age 18 - 90 years
  • Informed consent

Who cannot join

  • Pregnancy
  • Urogenital anatomical abnormality
  • Evidence of kidney stones
  • Indwelling catheter
  • systemic diseases such as renal insufficiency, transplantation, diabetes, or immunodeficiency

Trial locations and contacts

1 site in 1 country.

Austria1 site
  • Department of Gynecology/ Medical University of Graz

    Graz, 8036

Other trials in Austria

About this study

Official title: Segmental and Ear Acupuncture for Prevention of Recurrent Urinary Tract Infections(SARUTI Study): a Multicenter Randomized Controlled Trial

In this multi-centre prospective randomized controlled trial the efficacy of segmental acupuncture in the prevention of recurrent urinary tract infections will be assessed. The study (acupuncture) group will receive 12 acupuncture treatments according to a standardized protocol, plus recommendation for use of cranberry products. The control group will receive recommendation for use of cranberry products only.

Read the detailed description
  1. Background 1.1. Urinary tract infection Urinary tract infections (UTI) are considered to be the most common bacterial infections, with approximately 80% of all UTIs occurring in women (1). Nearly one in three women is expected to have at least one episode of UTI by the age of 24 years and almost half of all women will experience one UTI during their lifetime (2). Recurrence affect approximately 20-30% of women with initial UTI, although recurrence rates vary widely (3). Recurrent UTIs are a common problem seen in clinical practice with important medical, social and financial implications. Prophylaxis of recurrent UTI is an ongoing challenge with several different management strategies being used (4). Low dose antibiotic prophylaxis for several months is effective, but fosters the development of antibiotic resistance of the causative microorganisms, but also the commensal flora.(4-8). In postmenopausal women vaginal estrogen therapy reduces symptomatic UTI episodes (1, 7). Further prevention strategies include the oral immunostimulant OM-89, the vaginal vaccine Urovac, lactobacilli prophylaxis, cranberry products and acupuncture (5, 7, 9). 1.2.Cranberry products Cranberries have been used in the prevention of UTIs for many years. Cranberries contain two compounds with antiadherence properties that prevent fimbriated Escherichia coli from adhering to uroepithelial cells in the urinary tract (10). A recent review of 24 studies showed that the use of various cranberry products may have a small benefit for women with recurrent UTIs, although differences were not statistically significant (11). 1.3. Acupuncture treatment The effectiveness of acupuncture has been established for a series of different conditions (12, 13). Up to date there are only two clinical trials studying the effect of acupuncture on the prevention of recurrent UTI, both conducted from the same research group. In one controlled trial of 67 adult women acupuncture was significantly more effective in preventing recurrent UTI compared to sham acupuncture than no treatment over an observation period of 6 months (14). In the second trial of 100 women acupuncture, administered twice weekly for 4 weeks, was significantly more effective in reducing the number of UTIs, but also in reducing the volume of residual urine. Acupuncture points were chosen according to patients´ individual diagnoses following traditional Chinese medical patterns. (15)
  2. Study aims The present study aims to compare acupuncture treatment with standard treatment (recommendation for cranberry intake) in the treatment of uncomplicated recurrent UTIs in women and is designed as a prospective randomized controlled trial. We will assess the number of acute lower UTIs and subsequent treatment, the type and amount of self medication (cranberry products and others), health related quality of life and treatment satisfaction within a defined period of time. The results from this study will help to guide clinical practice with level I evidence and allow for effective treatment with regard to patient needs.
  3. Methods/ Workplan This patient oriented non-profit clinical study is designed as a randomised controlled trial (6 months) with a follow-up period of 12 months.

Active recruitment: 12 months Randomised controlled trial: 6 months Short-term Follow-up: 12 months 3.1. Active recruitment After Ethics Committee approval patient recruitment will be started. Information material about the study, including contact details, will be provided at the outpatient clinics of the Dep. of Gynecology, the Dep. of Urology, and other local health care providers. During an initial visit patients will be informed about the study and inclusion and exclusion criteria will be evaluated. A structured medical history, including assessment of previous UTIs and other urogenital tract symptoms, will be obtained. After written informed consent is obtained participants will be randomized.

3.2. Randomized Controlled Trial (6 months)

At the time of randomization patients must not have signs or symptoms of an acute UTI, and must not currently receive antibiotic treatment. Randomizing will be done electronically (www.randomizer.at). Patients will be randomized in one of two treatment groups without stratification with a planned ratio of 1:1:

  • Acupuncture treatment group 12 acupuncture treatments according to a standardized protocol plus recommendation for use of cranberry products
  • Standard treatment group Recommendation for use of cranberry products only

Participants will be contacted bimonthly by telephone and asked about occurrence of UTIs, adverse events, study adherence and completion of study diary. At 6 months a control visit will be scheduled, the RCT will be completed and the main outcome parameter (number of women with no acute UTIs) and secondary outcome parameters (9.2.) will be assessed.

This will be followed by a 12 months short-term Follow-up. 3.3. Short-term Follow-up (12 months) Patients of both treatment groups may use any prophylactic treatment. Participants will be contacted bimonthly by telephone and asked about occurrence of UTIs, adverse events, and use of prophylactic and therapeutic treatments for UTIs.

The study is designed according to the 2010 CONSORT guidelines(16) and the STRICTA (Standards for Reporting Interventions in Clinical Trials of Acupuncture) guidelines (17).

Being tested
acupuncture, Cranberry products
Medical subject headings
Urinary Tract Infections

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • acupunctureOther

    Acupuncture will be performed according to the physiological concept of segmental acupuncture. A fixed schema of acupuncture points will be used irrespective of TCM diagnosis. Needles will be inserted approximately 10 mm under the skin. The "deqi sensation" (a sensation described as numbness, heaviness, and distension) may be obtained, but will not be specifically aimed for. The acupuncture protocol includes body and ear acupuncture.

  • Cranberry productsDrug

    Also called Cranberry tablets and juice

    Participants will receive Cranberry products (Urgenin Blasenkapseln® and/or Alpinamed Preiselbeer Granulat ®) - use is recommended but not obligatory.

Study groups in NCT02705495
Study groupRoleWhat they receive
acupunctureActive comparator12 acupuncture treatments according to a standardized protocol, plus recommendation for use of cranberry products
Receives: Other: acupuncture; Drug: Cranberry products
ControlOtherRecommendation for use of cranberry products only
Receives: Drug: Cranberry products

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Urinary tract infection (UTI)

    Number of women with no acute UTI at 6 months

    Measured: 6 months

Secondary outcomes (3)
  1. Urinary symptoms

    Occurrence of urinary symptoms without signs of UTI

    Measured: 6 months

  2. Study diary

    Use of cranberry products (type, length and amount) assessed by the study diary

    Measured: 6 months

  3. Health related quality of life

    Health related quality of life as measured by the Kings Health Questionnaire

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Mar 2016 (estimated)
  2. Study startMay 2015
  3. Primary completionDec 2021
  4. Study completionJun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
136 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02705495
Sponsor's protocol ID
SARUTI V1.6
Acronym
SARUTI
Status last verified
Aug 2022
First submitted
1 Feb 2016
Last updated
5 Aug 2022
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing acupuncture and Cranberry products in people with Recurrent Urinary Tract Infection, run by Medical University of Graz at 1 site in Austria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Urinary tract infection (UTI) (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in